Efficacy and Safety of Infliximab Biosimilar in Treatment of Resistant Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa Intervention: Biological: Infliximab biosimilar Sponsor: Services Institute of Medical Sciences, Pakistan Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials